Progestins and coronary heart disease.
Cano
A
A
Department of Pediatrics, Obstetrics and Gynecology, Facultad de Medicina, Valencia, Spain.
D001161:Arteriosclerosis / Q000139:chemically induced / Q000517:prevention & control; D003271:Contraceptive Agents, Female / Q000009:adverse effects* / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology* / Q000517:prevention & control; D016889:Endometrial Neoplasms / Q000139:chemically induced; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D050356:Lipid Metabolism; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology; D011372:Progestins / Q000009:adverse effects*; D011980:Receptors, Progesterone / Q000502:physiology
D003271:Contraceptive Agents, Female; D004967:Estrogens; D011372:Progestins; D011980:Receptors, Progesterone